Literature DB >> 11506314

Generalized Wegener's granulomatosis responding to sulfamethoxazole-trimethoprim monotherapy.

T Ohtake1, S Kobayashi, Y Honjou, T Shirai, S Takayanagi, K Tohyama, Y Tokura, M Kimura.   

Abstract

Wegener's granulomatosis (WG) has two different clinical phases: the initial phase and generalized phase. In patients with generalized WG, both steroids and cyclophosphamide have generally been used. We report a case of generalized WG that was temporarily, but successfully treated with sulfamethoxazole-trimethoprim (S/T) alone. S/T therapy reduced the elevated levels of soluble IL-2 receptor and IL-6 in parallel with improvement of the patient's symptoms and urinary protein excretion. In view of the high incidence of lethal adverse effects of cytotoxic drugs, S/T monotherapy may be worth trying not only for initial phase WG but also for generalized WG with careful follow-up when the patient is not acutely ill.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506314     DOI: 10.2169/internalmedicine.40.666

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

Review 2.  Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  A Case of Granulomatosis with Polyangiitis (Wegener's Granulomatosis) Presenting with Rapidly Progressive Glomerulonephritis.

Authors:  Md Rockyb Hasan; Md Sakibuzzaman; Tahsin Tabassum; Syed Ahmad Moosa
Journal:  Cureus       Date:  2019-10-12

4.  Wegener's granulomatosis in a middle-aged woman presenting with dyspnea, rash, hemoptysis and recurrent eye complaints: a case report.

Authors:  Jose Cardenas-Garcia; Dimitrios Farmakiotis; Berta-Paola Baldovino; Peter Kim
Journal:  J Med Case Rep       Date:  2012-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.